CliffBio
small molecule

ESTRASORB

ESTRADIOL HEMIHYDRATE

Loss of exclusivity—loss of exclusivity
CompanyExeltis USA, Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameESTRASORB
Active ingredientESTRADIOL HEMIHYDRATE
Strength0.25%
Dosage formEMULSION
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2003
Marketing statusDISCN

More from Exeltis USA, Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ESTRASORB patent cliff — loss of exclusivity — | CliffBio